Global Muscle Relaxant Drug Market Size, Competitive Analysis, Share, Forecast- 2020-2026


Posted September 16, 2020 by preetipandey

The global muscle relaxant drug market is projected to grow significantly during the forecast period. Muscle relaxants are utilized to relax and reduce tension in the muscle

 
The global muscle relaxant drug market is projected to grow significantly during the forecast period. Muscle relaxants are utilized to relax and reduce tension in the muscle. It primarily cures two conditions including spasticity or rigidness of the muscles caused by cerebral palsy, multiple sclerosis; and muscle spasms which are tension headache, low back pain, or fibromyalgia. Some of the commonly used drugs include methocarbamol, baclofen, and tizanidine that blocks over-excited neuronal pathways in the brain or spinal cord. Whereas dantrolene and botulinum toxins act directly on the muscle.
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/muscle-relaxant-drug-market
The key factors that drive the growth of the market include the rising geriatric population. The aging population is projected to increase significantly during the forecast period. According to WHO, the geriatric population is going to be double in 2050 as compared to 2000. Globally, in 2000, the proportion of the population over 65 years was 11.0%, which is expected to reach 22.0% by 2050. Older age is a primary risk factor, as they are more prone to diseases as well as muscle and joint pains. Thus, this is likely to increase the growth of the market during the forecast period.
Browse for Full Report [email protected] https://www.omrglobal.com/request-sample/muscle-relaxant-drug-market
Additionally, increased focus of the key players on the development of novel drugs for the treatment of pain, rapid drug approvals, increased number of surgeries is some other factors that fuel the market growth during the forecast period. However, side effects associated with the muscle relaxant drugs is challenging the market growth. Besides, the key players are expected to provide growth opportunities to the market by various product launches and drug innovations. For instance, in March 2017, Cadila Healthcare Ltd. received approval from the US FDA to market a muscle relaxant named tizanidine hydrochloride capsules, in the US market.
Market Segmentation
Global Muscle Relaxant Drug Market by Product Type
• Peripherally Acting Muscle Relaxants
• Facial Aesthetic Relaxants
• Centrally Acting Muscle Relaxants
Global Muscle Relaxant Drug Market by Formulation
• Oral
• Injectable
Regional Analysis
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• Rest of Asia-Pacific
Rest of the World
Company Profiles
• AbbVie Inc.
• Acorda Therapeutics Inc.
• Aurobindo Pharma Ltd.
• Cadila Healthcare Ltd.
• Dr. Reddy's Laboratories Ltd.
• Endo Pharmaceuticals Inc.
• Ipsen Biopharmaceuticals Inc.
• Johnson & Johnson Services Inc.
• Merck & Co. Inc.
• Mylan NV
• Neurana Pharmaceuticals
• Novartis International AG
• Orient Pharma Co. Ltd.
• Par Pharmaceutical Inc.
• Pfizer Inc.
• Vertical Pharmaceuticals LLC
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/muscle-relaxant-drug-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By preeti
Country India
Categories Business
Tags Global Muscle Relaxant Drug Market
Last Updated September 16, 2020